Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 7, 2012, Pages 617-623

  Saito, Makoto ^a   Okayama, Hideki ^b   Yoshii, Toyofumi ^a   Higashi, Haruhiko ^a   Morioka, Hiroe ^a   Hiasa, Go ^a   Sumimoto, Takumi ^a   Inaba, Shinji ^c   Nishimura, Kazuhisa ^c   Inoue, Katsuji ^c   Ogimoto, Akiyoshi ^c   Shigematsu, Yuji ^c   Hamada, Mareomi ^d   Higaki, Jitsuo ^c  

^a Kitaishikai Hospital   (Japan)

^b EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Uwajima City Hospital   (Japan)

Author keywords

Cardiac events; Global strain; Hypertrophic cardiomyopathy; Myocardial fibrosis

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLOBAL LONGITUDINAL STRAIN; HEART DISEASE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ENDOMYOCARDIAL FIBROSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS;

EID: 84863868075     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ejechocard/jer318     Document Type: Article

References (42)

1. Jellis C, Martin J, Narula J, Marwick TH. Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 2010;56:89-97.
2. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7. (Pubitemid 36543376)
3. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
4. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
5. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4. (Pubitemid 38757595)
6. Papavassiliu T, Schnabel P, Schröder M, Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 2005;26:2395. (Pubitemid 41552968)
7. Saito M, Okayama H, Yoshii T, Hiasa G, Sumimoto T, Inaba S et al. Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy. J Cardiovasc Pharmacol 2011;57:207-12.
8. Motoyasu M, Kurita T, Onishi K, Uemura S, Tanigawa T, Okinaka T et al. Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J 2008;72:1449-53.
9. Greenberg NL, Firstenberg MS, Castro PL, Main M, Travaglini A, Odabashian JA et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 2002;105:99-105. (Pubitemid 34049149)
10. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 2004;17:1021-9. (Pubitemid 39273478)
11. Inoue K, Okayama H, Nishimura K, Saito M, Yoshii T, Hiasa G et al. Right ventricular septal pacing preserves global left ventricular longitudinal function in comparison with apical pacing. Circ J 2011;75:1609-15.
12. Saito M, Okayama H, Nishimura K, Ogimoto A, Ohtsuka T, Inoue K et al. Determinants of left ventricular untwisting behaviour in patients with dilated cardiomyopathy: analysis by two-dimensional speckle tracking. Heart 2009;95:290-6.
13. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1175-81.
14. Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F et al. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2009;2:314-21.
15. Saito M, Okayama H, Yoshii T, Hiasa G, Sumimoto T, Inaba S et al. The differences in left ventricular torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive heart disease. Int J Cardiol 2011;150:301-6.
16. Popović ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 2008;21:1299-305.
17. Matsunaka T, Hamada M, Matsumoto Y, Higaki J. First-pass myocardial perfusion defect and delayed contrast enhancement in hypertrophic cardiomyopathy assessed with MRI. Magn Reson Med Sci 2003;2:61-9.
18. Choudhury L, Mahrholdt H,Wagner A, Choi KM, Elliott MD, Klocke FJ et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64. (Pubitemid 36005903)
19. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2. (Pubitemid 26074816)
20. Hamada M, Shigematsu Y, Kawakami H, Minamino N, Kangawa K, Matsuo H et al. Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenaline. Clin Sci (Lond) 1998;94:21-8. (Pubitemid 28029804)
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
22. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33. (Pubitemid 27486472)
23. Takatsuji H, Mikami T, Urasawa K, Teranishi J, Onozuka H, Takagi C et al. A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography. J Am Coll Cardiol 1996;27:365-71. (Pubitemid 26045503)
24. Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C et al. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr 2010;23:1019-24.
25. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42. (Pubitemid 34262671)
26. Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009;53:284-91.
27. Nahum J, Bensaid A, Dussault C, Macron L, Clémence D, Bouhemad B et al. Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Cardiovasc Imaging 2010;3:249-56.
28. Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol 2007;100:128-32. (Pubitemid 46961909)
29. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010;3:51-8.
30. Yang H, Sun JP, Lever HM, Popovic ZB, Drinko JK, Greenberg NL et al. Use of strain imaging in detecting segmental dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2003;16:233-9. (Pubitemid 36397617)
31. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF. Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 2008;29:1283-9. (Pubitemid 351768130)
32. Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008;1:184-91.
33. Antoni ML, Mollema SA, Delgado V, Atary JZ, Borleffs CJ, Boersma E et al. Prognostic importance of strain and strain rate after acute myocardial infarction. Eur Heart J 2010;31:1640-7.
34. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr 2008;21:1138-44.
35. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-74. (Pubitemid 351443083)
36. Fluechter S, Kuschyk J, Wolpert C, Doesch C, Veltmann C, Haghi D et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010;12:30.
37. Teraoka K, Hirano M, Ookubo H, Sasaki K, Katsuyama H, Amino M et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004;22:155-61. (Pubitemid 38326634)
38. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-73.
39. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N et al. Slow conduction in the infarcted human heart: zigzag course of activation. Circulation 1993;88:915-26.
40. Aryana A, d'Avila A, Heist EK, Mela T, Singh JP, Ruskin JN et al. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation 2007;115:1191-200. (Pubitemid 46594762)
41. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216-25. (Pubitemid 44297115)
42. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20. (Pubitemid 34250486)